Laraway Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Laraway Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.08M	Sell	2,188 -125	-5%	-$67.8K	0.76%	37
2025 Q4	$1.34M	Sell	2,313 -5	-0.2%	-$2.83K	0.87%	30
2025 Q3	$1.12M	Hold	2,318	–	–	0.77%	34
2025 Q2	$940K	Sell	2,318 -100	-4%	-$41.8K	0.71%	37
2025 Q1	$1.2M	Hold	2,418	–	–	0.96%	29
2024 Q4	$1.26M	Hold	2,418	–	–	0.97%	29
2024 Q3	$1.5M	Hold	2,418	–	–	1.19%	24
2024 Q2	$1.34M	Hold	2,418	–	–	1.14%	25
2024 Q1	$1.41M	Sell	2,418 -50	-2%	-$28.1K	1.24%	22
2023 Q4	$1.31M	Hold	2,468	–	–	1.24%	23
2023 Q3	$1.25M	Hold	2,468	–	–	1.3%	21
2023 Q2	$1.29M	Sell	2,468 -190	-7%	-$103K	1.27%	23
2023 Q1	$1.53M	Sell	2,658 -188	-7%	-$106K	1.55%	17
2022 Q4	$1.57M	Sell	2,846 -34	-1%	-$18K	1.64%	15
2022 Q3	$1.46M	Hold	2,880	–	–	1.63%	16
2022 Q2	$1.56M	Sell	2,880 -160	-5%	-$88.1K	1.66%	17
2022 Q1	$1.79M	Sell	3,040 -60	-2%	-$34.5K	1.63%	19
2021 Q4	$2.07M	Buy	+3,100	New	+$1.94M	1.85%	17

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Laraway Financial Advisors's TMO Position: Q1 2026 in Review

Laraway Financial Advisors reduced its Thermo Fisher Scientific (TMO) stake by 5.4% in Q1 2026, selling an estimated $67.8K and leaving 2,188 shares worth $1.08M. The position accounts for 0.76% of the portfolio, ranked #37.

Laraway Financial Advisors first reported a position in TMO in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.07M in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Laraway Financial Advisors held 2,188 shares of Thermo Fisher Scientific worth $1.08M as of Q1 2026.
Laraway Financial Advisors sold 125 Thermo Fisher Scientific shares in Q1 2026, an estimated $67.8K.
Thermo Fisher Scientific made up 0.76% of Laraway Financial Advisors's portfolio in Q1 2026, its #37 holding.
Laraway Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 18 quarters since.
Laraway Financial Advisors's Thermo Fisher Scientific position peaked at $2.07M in Q4 2021.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Laraway Financial Advisors's 13F filing for Q1 2026, filed 14 May 2026.